Latest Period
n/a
Security Snapshot
Grace Therapeutics, Inc. - Common Stock (ACST) Institutional Ownership
CUSIP: 00430K865
13F Institutional Holders and Ownership History from Q3 2023 to Q4 2024
Institutions Reporting
Shares (Excl. Options)
Price
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.
- Type / Class
- Equity / Common Stock
- Symbol
- ACST
- Shares outstanding
- 16,612,245
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- ACST - Grace Therapeutics, Inc. - Common Stock is tracked under CUSIP 00430K865.
- Latest finished 13F holder period is not available.
- 2 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 11 to 0 between Q3 2024 and Q4 2024.
- Reported value moved from $3,483,534 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Investment Quick Answers
What is CUSIP 00430K865?
CUSIP 00430K865 identifies ACST - Grace Therapeutics, Inc. - Common Stock in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00430K865:
Significant Owners of Grace Therapeutics, Inc. - Common Stock (ACST) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ADAR1 Capital Management, LLC | 9.9% | -0.9% | 1,534,254 | +2.1% | ADAR1 Capital Management GP, LLC | 30 Sep 2025 | ||
| HIRSCHMAN ORIN | 4.9% | 814,000 | Orin Hirschman | 31 Mar 2026 |
Institutional Holders of Grace Therapeutics, Inc. - Common Stock (ACST) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2024 Q4 | 0 | $0 | -$3,483,534 | 0 | |
| 2024 Q3 | 1,159,981 | $3,483,534 | -$2,904,199 | $3.00 | 11 |
| 2024 Q2 | 2,152,387 | $6,299,610 | +$2,590,846 | $2.93 | 12 |
| 2024 Q1 | 1,265,432 | $4,337,046 | +$2,382,665 | $3.42 | 10 |
| 2023 Q4 | 571,277 | $1,651,298 | -$144,314 | $2.89 | 9 |
| 2023 Q3 | 557,722 | $1,550,341 | +$1,550,341 | $2.78 | 10 |